MEDICA 2024 is over!

From November 11th to 14th, we were showcasing at Medica, Hall 3, stand A92. We presented the latest in diagnostic innovation, featuring all BioVendor Group companies.

This year we put the spotlight on three powerful projects: CLIA, MBA, and NGS - all developed in synergy across the BioVendor Group. Our key highlight? The revolutionary MxA biomarker, designed to differentiate bacterial from viral infections, paving the way for precise, personalized treatments. This groundbreaking marker is available on three platforms: CLIA, ELISA, and POCT.

A huge thank to everyone who visited our booth – it was amazing meeting you! Your support and interest drive us forward.

We are excited to see you again next year!

Medica 2024